C Feyerabend

11.3k total citations · 2 hit papers
105 papers, 9.1k citations indexed

About

C Feyerabend is a scholar working on Physiology, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, C Feyerabend has authored 105 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 26 papers in Molecular Biology and 17 papers in Health, Toxicology and Mutagenesis. Recurrent topics in C Feyerabend's work include Smoking Behavior and Cessation (65 papers), Nicotinic Acetylcholine Receptors Study (25 papers) and Air Quality and Health Impacts (14 papers). C Feyerabend is often cited by papers focused on Smoking Behavior and Cessation (65 papers), Nicotinic Acetylcholine Receptors Study (25 papers) and Air Quality and Health Impacts (14 papers). C Feyerabend collaborates with scholars based in United Kingdom, United States and Bulgaria. C Feyerabend's co-authors include Michael A. Russell, M. J. Jarvis, C.J. VESEY, H Tunstall-Pedoe, Yussuf Saloojee, P. V. Cole, Radhika Iyer, Andrew Bryant, Robert West and J A Stapleton and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

C Feyerabend

104 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of tests used to distinguish smokers from nonsmokers.

1987 862 citations M. J. Jarvis, C Feyerabend et al. profile →
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.

1980 391 citations Michael A. Russell, M. J. Jarvis et al. BMJ profile →

Peers

Countries citing papers authored by C Feyerabend

Since Specialization

Citations

This map shows the geographic impact of C Feyerabend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Feyerabend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Feyerabend more than expected).

Fields of papers citing papers by C Feyerabend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Feyerabend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Feyerabend. The network helps show where C Feyerabend may publish in the future.

Co-authorship network of co-authors of C Feyerabend

This figure shows the co-authorship network connecting the top 25 collaborators of C Feyerabend. A scholar is included among the top collaborators of C Feyerabend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Feyerabend. C Feyerabend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults 2010 ·Heart ·Barbara J. Jefferis, Debbie A. Lawlor, Shah Ebrahim, S. Goya Wannamethee, C Feyerabend, Mira Doig, Laura J. McMeekin, Derek G. Cook, Peter H. Whincup	51
2	Changes in environmental tobacco smoke (ETS) exposure over a 20‐year period: cross‐sectional and longitudinal analyses 2009 ·Addiction ·Barbara J. Jefferis, A. G. Thomson, Lucy Lennon, C Feyerabend, Mira Doig, Laura J. McMeekin, S. Goya Wannamethee, Derek G. Cook, Peter H. Whincup	12
3	Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine 2004 ·Alimentary Pharmacology & Therapeutics ·John R Ingram, Philip A. Routledge, J. Rhodes, R. W. Marshall, (unknown), B K Evans, C Feyerabend, Gareth Thomas	21
4	Pharmacokinetics of nicotine carbomer enemas: A new treatment modality for ulcerative colitis 1997 ·Clinical Pharmacology & Therapeutics ·John T. Green, Gareth Thomas, J. Rhodes, B K Evans, Michael A. Russell, C Feyerabend, (unknown), Robert G. Newcombe, William J. Sandborn	23
5	Is Transdermal Nicotine Associated with Cardiovascular Risk? 1995 ·Journal of the Royal College of Physicians of London ·Gareth Thomas, S. Davies, J. Rhodes, M A Russell, C Feyerabend, Urbain Säwe	28
6	Naltrexone, smoking behaviour and cigarette withdrawal 1995 ·Psychopharmacology ·G Sutherland, J A Stapleton, Michael A. Russell, C Feyerabend	79
7	Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study 1992 ·Psychopharmacology ·Jonathan Foulds, John Stapleton, C Feyerabend, C.J. VESEY, M. J. Jarvis, Michael A. Russell	98
8	Transdermal nicotine in active ulcerative colitis 1991 ·European Journal of Gastroenterology & Hepatology ·E D Srivastava, Muir Russell, C Feyerabend, G T Williams, (unknown), J. Rhodes	28
9	Effect of ulcerative colitis and smoking on rectal blood flow. 1990 ·Gut ·E D Srivastava, Michael A. Russell, C Feyerabend, J. Rhodes	63
10	Passive smoking and middle ear effusion in children: Authors' reply 1989 ·BMJ ·David P. Strachan, M. J. Jarvis, C Feyerabend	7
11	Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. 1989 ·BMJ ·David P. Strachan, M. J. Jarvis, C Feyerabend	120
12	Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study 1989 ·Psychopharmacology ·Peter Hájek, M. J. Jarvis, Michael Belcher, G Sutherland, C Feyerabend	36
13	Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. 1985 ·BMJ ·M. J. Jarvis, Melissa Russell, C Feyerabend, J. Richard Eiser, Michelle Morgan, Philip Gammage, Elspeth Gray	114
14	Nasal nicotine solution: a potential aid to giving up smoking? 1983 ·BMJ ·Michael A. Russell, M. J. Jarvis, C Feyerabend, (unknown)	62
15	Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation? 1982 ·BMJ ·Stephen Sutton, Michael A. Russell, Radhika Iyer, C Feyerabend, Yussuf Saloojee	63
16	Comparison of nicotine chewing-gum and psychological treatments for dependent smokers. 1980 ·BMJ ·Martin Raw, M. J. Jarvis, C Feyerabend, Michael A. Russell	68
17	Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. breakdown → 1980 ·BMJ ·Michael A. Russell, M. J. Jarvis, Radhika Iyer, C Feyerabend	391
18	Smokers' response to shortened cigarettes: Dose reduction without dilution of tobacco smoke 1980 ·Clinical Pharmacology & Therapeutics ·Michael A. Russell, Stephen Sutton, C Feyerabend, Yussuf Saloojee	22
19	The effect of nicotine on fetal breathing movements in conscious pregnant ewes. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Frank A. Manning, David W. Walker, C Feyerabend	28
20	Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. 1976 ·BMJ ·M A Russell, Caroline Wilson, C Feyerabend, P. V. Cole	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact